Contact this trialFirst, we need to learn more about you.
Virus Therapy
NEO-201 + Pembrolizumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing a new cancer drug, NEO-201, to see if it is safe and effective. So far, the results look promising, with the Maximum Tolerated Dose being 1.5mg/kg. The Expansion Phase of the study is now enrolling patients with non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical and uterine cancers.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.